Sandoz

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

Sandoz expands biosimilar collaboration with Samsung Bioepis

Mar 18, 2026 11:05am

Sandoz to break its biosimilars business out from generics

Mar 10, 2026 4:01pm

Biosimilar execs optimistic about future for US biosims

Jan 22, 2026 12:56pm

JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26

Jan 13, 2026 7:29pm

Sandoz's biosimilar to Biogen's Tysabri hits the US after delay

Nov 17, 2025 11:12am